Bread lovers, rejoice! There may soon be an efficient treatment for your celiac’s disease that will allow you to indulge your love of pasta once more.
Celiac disease is an autoimmune disorder that affects by some estimates nearly 1 in 100 people. Celiac disease symptoms are triggered by gluten, a protein found in wheat and related plants, but gluten doesn’t act alone to cause the digestive symptoms that patients suffer. Rather, gluten induces an overactive immune response when it’s modified by the enzyme transglutaminase 2, or TG2, in the small intestine. New research published in the Feb. 23 issue of the Journal of Biological Chemistry identifies an enzyme that turns off TG2, potentially paving the way for new treatments for celiac disease.
“Currently, therapies to treat people with celiac disease are lacking. The best approach right now is just a strict adherence to a lifelong gluten-free diet,” said Michael Yi, a chemical engineering graduate student at Stanford University who led the new study. “Perhaps the reason behind this is our relatively poor understanding of TG2.”
The biochemistry of how TG2 interacts with gluten and induces an immune response has been well studied, but more basic mysteries remain, for example how TG2 behaves in people without celiac disease. Chaitan Khosla, the professor at…
I have a crazy passion for #music, #celebrity #news & #fashion! I'm always out and about on Twitter.
Latest posts by Sasha Harriet (see all)
- Newly Unearthed Civil War Bones Speak Silently to the Grim Aftermath of Battle - June 24, 2018
- 13 Movie and TV Jokes that Took Years to Deliver - June 24, 2018
- Chip and Joanna Gaines Welcome Son: ‘The Gaines Crew Is Now 1 Stronger!’ - June 24, 2018
More from Around the Web